Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Not yet recruiting
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma
NCT07535762· Phase 2· Shanghai Jiao Tong University School of Medicine· Source
Contact: Jiong Hu
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error